Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $904.95 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $167.67 | 15 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $128.32 | 2 | $0 (2021) |
| Amgen Inc. | $114.27 | 6 | $0 (2023) |
| SANOFI PASTEUR INC. | $100.11 | 2 | $0 (2021) |
| Lilly USA, LLC | $62.22 | 1 | $0 (2017) |
| PFIZER INC. | $56.68 | 3 | $0 (2023) |
| Allergan, Inc. | $44.82 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $37.42 | 2 | $0 (2021) |
| Abbott Laboratories | $32.39 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $25.23 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $76.41 | 5 | PFIZER INC. ($22.00) |
| 2022 | $87.15 | 6 | Amgen Inc. ($31.11) |
| 2021 | $370.20 | 20 | AbbVie Inc. ($139.51) |
| 2020 | $93.09 | 6 | Allergan, Inc. ($44.82) |
| 2019 | $27.91 | 2 | PFIZER INC. ($14.71) |
| 2018 | $60.41 | 4 | PFIZER INC. ($19.97) |
| 2017 | $189.78 | 5 | SANOFI PASTEUR INC. ($82.07) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Diabetes | ||||||
| 06/06/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/29/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: INSOMNIA | ||||||
| 02/08/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: VACCINES | ||||||
| 01/30/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 12/15/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes Care | ||||||
| 07/07/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Bone Health | ||||||
| 01/11/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Inflammation | ||||||
| 11/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Cardiology | ||||||
| 08/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: PRIMARY CARE | ||||||
| 06/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $115.56 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2021 | SANOFI PASTEUR INC. | VAXELIS (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Vaccines | ||||||
| 05/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 4,378 | 6,278 | $346,956 | $188,345 |
| 2022 | 42 | 3,819 | 5,112 | $240,684 | $117,384 |
| 2021 | 45 | 4,298 | 5,674 | $269,415 | $138,944 |
| 2020 | 42 | 3,949 | 6,314 | $256,416 | $116,907 |
All Medicare Procedures & Services
171 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 117 | 120 | $45,000 | $33,855 | 75.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 516 | $56,760 | $28,445 | 50.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 178 | 674 | $49,876 | $27,749 | 55.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 194 | 194 | $33,950 | $22,525 | 66.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 206 | $33,318 | $15,971 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 120 | 123 | $10,701 | $8,765 | 81.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 607 | $8,496 | $5,074 | 59.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 128 | 131 | $5,240 | $3,590 | 68.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 116 | 119 | $4,760 | $3,312 | 69.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 253 | 379 | $7,955 | $3,103 | 39.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 189 | 189 | $5,859 | $3,072 | 52.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 258 | 387 | $6,963 | $2,889 | 41.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 80 | 80 | $5,336 | $2,609 | 48.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 19 | $4,655 | $2,450 | 52.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 179 | 183 | $7,320 | $2,366 | 32.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 66 | 78 | $7,020 | $2,238 | 31.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 210 | 282 | $5,918 | $2,229 | 37.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 110 | 136 | $5,568 | $2,211 | 39.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,900 | $1,945 | 49.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 253 | 415 | $3,735 | $1,268 | 33.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 89 | 130 | $3,120 | $1,238 | 39.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $2,294 | $1,193 | 52.0% |
| 83721 | Ldl cholesterol level | Office | 2023 | 100 | 113 | $2,599 | $1,152 | 44.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 176 | 199 | $2,388 | $1,115 | 46.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 178 | 202 | $3,838 | $1,016 | 26.5% |
About Dr. Harold Short, MD
Dr. Harold Short, MD is a Family Medicine healthcare provider based in Jacksonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952307860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Short, MD has received a total of $904.95 in payments from pharmaceutical and medical device companies, with $76.41 received in 2023. These payments were reported across 48 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($904.95).
As a Medicare-enrolled provider, Short has provided services to 16,444 Medicare beneficiaries, totaling 23,378 services with total Medicare billing of $561,580. Data is available for 4 years (2020–2023), covering 171 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Jacksonville, AR
- Active Since 06/24/2005
- Last Updated 10/29/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952307860
Products in Payments
- UBRELVY (Drug) $149.12
- NURTEC ODT (Drug) $128.32
- FLUZONE HIGH-DOSE (Drug) $82.07
- TRULICITY (Drug) $62.22
- Otezla (Drug) $52.05
- VRAYLAR (Drug) $47.54
- EVENITY (Biological) $33.54
- Repatha (Biological) $28.68
- BELSOMRA (Drug) $23.53
- PREVNAR 20 (Biological) $22.00
- LYRICA (Drug) $19.97
- VAXELIS (Biological) $18.04
- NEUROSTAR TMS THERAPY (Device) $17.08
- FreeStyle Lite system (Device) $16.91
- INVOKANA (Drug) $16.01
- QULIPTA (Drug) $15.83
- FREESTYLE LIBRE (Device) $15.48
- QUVIVIQ (Drug) $14.85
- PREVNAR - 13 (Biological) $14.71
- TRELEGY ELLIPTA (Drug) $14.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jacksonville
Colin Lacroix, M.d, M.D
Family Medicine — Payments: $94,208
Dr. Sarfaraz Dhanji, Md, MD
Family Medicine — Payments: $48,705
Dr. Kim Barbel-Johnson, D.o, D.O
Family Medicine — Payments: $46,143
Victor Micolucci, M.d, M.D
Family Medicine — Payments: $39,554
Herman Downey, Md, MD
Family Medicine — Payments: $32,440
William Schwartz, D.o, D.O
Family Medicine — Payments: $32,173